Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects

Inclusion Criteria: * Caucasian * Body Mass Index (BMI) between 18 and 27 kg/m\^2, both inclusive * Good health as indicated by medical history, physical examination including vital signs and ECG, and clinical laboratory test results * Smoke less than 10 cigarettes (or equivalent) per day * Capable of giving written Informed Consent (IC) Exclusion Criteria: * Evidence of clinically relevant pathology or potential thromboembolic risk based on medical and/or family history as judged by the Investigator * Known history of atherosclerosis, arteriosclerosis, thromboembolic events or known high levels of Troponin I * Known or suspected allergy to activated recombinant human factor VII or related products or any of the components of the formulation * Overt bleeding, including from gastrointestinal tract * Hepatitis (B or C) infection * HIV (human immunodeficiency virus) infection